Derik De Bruin
Stock Analyst at B of A Securities
(4.31)
# 131
Out of 4,479 analysts
115
Total ratings
60.78%
Success rate
11.28%
Average return
Main Sectors:
31 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Neutral | $134 → $140 | $127.40 | +9.89% | 15 | Jun 25, 2024 | |
| BRKR Bruker | Maintains: Buy | $95 → $90 | $62.33 | +44.39% | 2 | May 20, 2024 | |
| FTRE Fortrea Holdings | Maintains: Underperform | $33 → $27 | $23.86 | +13.16% | 3 | May 14, 2024 | |
| TXG 10x Genomics | Maintains: Neutral | $45 → $36 | $18.59 | +93.65% | 5 | May 1, 2024 | |
| DHR Danaher | Maintains: Neutral | $258 → $270 | $244.51 | +10.42% | 2 | Apr 24, 2024 | |
| SDGR Schrödinger | Maintains: Neutral | $38 → $32 | $18.76 | +70.58% | 1 | Feb 29, 2024 | |
| ILMN Illumina | Downgrades: Underperform | $140 → $100 | $105.50 | -5.21% | 5 | Dec 12, 2023 | |
| DGX Quest Diagnostics | Upgrades: Buy | $140 → $160 | $137.09 | +16.71% | 4 | Dec 12, 2023 | |
| TMO Thermo Fisher | Maintains: Buy | $575 | $541.72 | +6.14% | 12 | Oct 25, 2023 | |
| LH Labcorp Holdings | Maintains: Buy | $238 → $230 | $203.13 | +13.23% | 2 | Sep 21, 2023 | |
| CTLT Catalent | Maintains: Underperform | $39 → $46 | $56.16 | -18.09% | 7 | Aug 31, 2023 | |
| CRL Charles River Laboratories International | Maintains: Buy | $235 → $245 | $203.24 | +20.55% | 3 | Aug 10, 2023 | |
| HOLX Hologic | Maintains: Neutral | $94 → $86 | $74.10 | +16.06% | 6 | Aug 1, 2023 | |
| STVN Stevanato Group | Maintains: Buy | $32 → $35 | $18.73 | +86.87% | 2 | Jun 16, 2023 | |
| EVO Evotec SE | Downgrades: Neutral | $13 | $4.86 | +167.49% | 1 | Jun 16, 2023 | |
| WST West Pharmaceutical Services | Upgrades: Buy | $390 → $405 | $324.55 | +24.79% | 6 | Jun 16, 2023 | |
| WAT Waters | Maintains: Neutral | $350 → $315 | $282.70 | +11.43% | 6 | May 10, 2023 | |
| EXAS Exact Sciences | Maintains: Buy | $80 → $88 | $42.43 | +107.40% | 5 | May 10, 2023 | |
| MTD Mettler-Toledo International | Maintains: Neutral | $1,650 → $1,525 | $1,366.84 | +11.57% | 4 | May 8, 2023 | |
| NEO NeoGenomics | Maintains: Neutral | $18 → $17 | $13.93 | +22.04% | 3 | Apr 11, 2023 | |
| SEER Seer, Inc. | Downgrades: Underperform | $9 → $6.5 | $1.69 | +284.62% | 1 | Jan 4, 2023 | |
| ICLR ICON PLC | Upgrades: Buy | $265 → $260 | $316.51 | -17.85% | 1 | Nov 9, 2022 | |
| DNA Ginkgo Bioworks Holdings | Downgrades: Underperform | $6 → $3 | $0.32 | +828.22% | 3 | May 18, 2022 | |
| TLIS Talis Biomedical | Maintains: Underperform | $45 → $23 | $8.43 | +166.90% | 3 | Mar 16, 2022 | |
| QGEN Qiagen | Upgrades: Buy | $61 | $40.23 | +51.06% | 4 | Oct 6, 2020 | |
| IQV IQVIA Holdings | Maintains: Buy | n/a | $208.49 | - | 1 | Jul 7, 2020 | |
| MYGN Myriad Genetics | Reiterates: Underperform | n/a | $23.97 | - | 3 | Apr 2, 2020 | |
| IDXX IDEXX Laboratories | Maintains: Buy | n/a | $476.40 | - | 2 | Nov 2, 2018 | |
| ZTS Zoetis | Maintains: Buy | n/a | $172.58 | - | 1 | Jul 30, 2018 | |
| DDD 3D Systems | Downgrades: Underperform | n/a | $2.97 | - | 1 | Nov 1, 2017 | |
| PAHC Phibro Animal Health | Reinstates: Underperform | n/a | $17.04 | - | 1 | Aug 23, 2017 |
Agilent Technologies
Jun 25, 2024
Maintains: Neutral
Price Target: $134 → $140
Current: $127.40
Upside: +9.89%
Bruker
May 20, 2024
Maintains: Buy
Price Target: $95 → $90
Current: $62.33
Upside: +44.39%
Fortrea Holdings
May 14, 2024
Maintains: Underperform
Price Target: $33 → $27
Current: $23.86
Upside: +13.16%
10x Genomics
May 1, 2024
Maintains: Neutral
Price Target: $45 → $36
Current: $18.59
Upside: +93.65%
Danaher
Apr 24, 2024
Maintains: Neutral
Price Target: $258 → $270
Current: $244.51
Upside: +10.42%
Schrödinger
Feb 29, 2024
Maintains: Neutral
Price Target: $38 → $32
Current: $18.76
Upside: +70.58%
Illumina
Dec 12, 2023
Downgrades: Underperform
Price Target: $140 → $100
Current: $105.50
Upside: -5.21%
Quest Diagnostics
Dec 12, 2023
Upgrades: Buy
Price Target: $140 → $160
Current: $137.09
Upside: +16.71%
Thermo Fisher
Oct 25, 2023
Maintains: Buy
Price Target: $575
Current: $541.72
Upside: +6.14%
Labcorp Holdings
Sep 21, 2023
Maintains: Buy
Price Target: $238 → $230
Current: $203.13
Upside: +13.23%
Catalent
Aug 31, 2023
Maintains: Underperform
Price Target: $39 → $46
Current: $56.16
Upside: -18.09%
Charles River Laboratories International
Aug 10, 2023
Maintains: Buy
Price Target: $235 → $245
Current: $203.24
Upside: +20.55%
Hologic
Aug 1, 2023
Maintains: Neutral
Price Target: $94 → $86
Current: $74.10
Upside: +16.06%
Stevanato Group
Jun 16, 2023
Maintains: Buy
Price Target: $32 → $35
Current: $18.73
Upside: +86.87%
Evotec SE
Jun 16, 2023
Downgrades: Neutral
Price Target: $13
Current: $4.86
Upside: +167.49%
West Pharmaceutical Services
Jun 16, 2023
Upgrades: Buy
Price Target: $390 → $405
Current: $324.55
Upside: +24.79%
Waters
May 10, 2023
Maintains: Neutral
Price Target: $350 → $315
Current: $282.70
Upside: +11.43%
Exact Sciences
May 10, 2023
Maintains: Buy
Price Target: $80 → $88
Current: $42.43
Upside: +107.40%
Mettler-Toledo International
May 8, 2023
Maintains: Neutral
Price Target: $1,650 → $1,525
Current: $1,366.84
Upside: +11.57%
NeoGenomics
Apr 11, 2023
Maintains: Neutral
Price Target: $18 → $17
Current: $13.93
Upside: +22.04%
Seer, Inc.
Jan 4, 2023
Downgrades: Underperform
Price Target: $9 → $6.5
Current: $1.69
Upside: +284.62%
ICON PLC
Nov 9, 2022
Upgrades: Buy
Price Target: $265 → $260
Current: $316.51
Upside: -17.85%
Ginkgo Bioworks Holdings
May 18, 2022
Downgrades: Underperform
Price Target: $6 → $3
Current: $0.32
Upside: +828.22%
Talis Biomedical
Mar 16, 2022
Maintains: Underperform
Price Target: $45 → $23
Current: $8.43
Upside: +166.90%
Qiagen
Oct 6, 2020
Upgrades: Buy
Price Target: $61
Current: $40.23
Upside: +51.06%
IQVIA Holdings
Jul 7, 2020
Maintains: Buy
Price Target: n/a
Current: $208.49
Upside: -
Myriad Genetics
Apr 2, 2020
Reiterates: Underperform
Price Target: n/a
Current: $23.97
Upside: -
IDEXX Laboratories
Nov 2, 2018
Maintains: Buy
Price Target: n/a
Current: $476.40
Upside: -
Zoetis
Jul 30, 2018
Maintains: Buy
Price Target: n/a
Current: $172.58
Upside: -
3D Systems
Nov 1, 2017
Downgrades: Underperform
Price Target: n/a
Current: $2.97
Upside: -
Phibro Animal Health
Aug 23, 2017
Reinstates: Underperform
Price Target: n/a
Current: $17.04
Upside: -